pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 13·1 min read
save

DOJ subpoenas signal start of criminal probe into gender-affirming care for minors

May 13, 2026·read at STAT ↗RegulatoryNeutral

Several hospitals have been served with grand jury subpoenas that request information about gender‑affirming treatments provided to minors, indicating that the Justice Department has opened a criminal investigation.

NYU Langone disclosed that the U.S. Attorney’s Office in the Northern District of Texas asked the hospital to turn over records covering patients from 2020 through 2026, including details on the minors, the clinicians who treated them, and other involved staff.

The subpoenas differ from earlier administrative requests, which did not require prior judicial approval. A grand jury summons suggests a higher level of legal scrutiny and potential criminal liability.

Policy experts note that this shift could affect how hospitals document and deliver gender‑affirming services, raising concerns about compliance and future legal exposure.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “New subpoena suggests DOJ has begun criminal investigation of gender-affirming care”

read at STAT ↗
1,060 words · retrieved May 13
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Psychiatry & CNS2Approval

related stories

  • May 8UT MD Anderson Shares Latest Research Breakthroughsonclive
  • May 8Former FDA leaders, pharma speak out on mifepristoneSTAT
  • May 8Dr Gruenbaum on Where Alternative Options to BTK Inhibitors Stand in MCLonclive
  • May 7STAT+: More political interference at the FDA?STAT
  • May 6Dr Chari on Frontline Combinations and Transplant Approaches in Multiple Myelomaonclive